SCHEMBL8695260

SCHEMBL8695260

Cc1ccc(NC(=O)Cc2ccc(OCC(C)C(=O)O)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.56
▸ GAA P10253 2/20 0.56
▸ RAB9A P51151 4/20 0.55
▸ HPGD P15428 3/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ MAPT P10636 4/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ KMT2A Q03164 7/20 0.51
▸ MEN1 O00255 4/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ CACNA1B Q00975 1/20 0.51
▸ APBA1 Q02410 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ LMNA P02545 2/20 0.50
▸ EPHX2 P34913 1/20 0.50
▸ TP53 P04637 1/20 0.49
▸ ADRB1 P08588 2/20 0.48
▸ ADRB3 P13945 2/20 0.48
▸ NLRP1 Q9C000 1/20 0.48
▸ HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8411536 0.90 RAB9A (0.61) SMN1; SMN2GAARAB9AHPGDNPC1
SCHEMBL8412806 0.89 GAA (0.61) SMN1; SMN2GAARAB9AHPGDNPC1
SCHEMBL8409841 0.89 SMN1; SMN2 (0.48) SMN1; SMN2GAARAB9AHPGDNPC1
SCHEMBL8410207 0.89 RAB9A (0.56) SMN1; SMN2GAARAB9AHPGDNPC1
SCHEMBL8411677 0.89 ADRB1 (0.57) SMN1; SMN2RAB9AHPGDNPC1MAPT
SCHEMBL8700685 0.86 EPHX2 (0.54) SMN1; SMN2RAB9AHPGDNPC1MAPT
SCHEMBL1304060 0.83 SMN1; SMN2 (0.55) SMN1; SMN2RAB9AHPGDNPC1MAPT
SCHEMBL8412730 0.83 SMN1; SMN2 (0.47) SMN1; SMN2RAB9AHPGDNPC1MAPT
SCHEMBL14273066 0.82 L3MBTL1 (0.53) GAAHPGDMAPTALDH1A1KMT2A
SCHEMBL2514423 0.82 FFAR1 (0.53) GAARAB9AHPGDNPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5731454-A Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood VIRGINIA COMMONWEALTH UNIVERSITY (US) 1998-03-24 — — US disclosed
US-5705521-A Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors THE CENTER FOR INNOVATIVE TECHNOLOGY (US) 1998-01-06 — — US disclosed
Send feedback